Perspective Therapeutics Statistics
Total Valuation
CATX has a market cap or net worth of $476.71 million. The enterprise value is $219.14 million.
Important Dates
The last earnings date was Monday, May 11, 2026, after market close.
| Earnings Date | May 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CATX has 114.05 million shares outstanding. The number of shares has increased by 16.38% in one year.
| Current Share Class | 114.05M |
| Shares Outstanding | 114.05M |
| Shares Change (YoY) | +16.38% |
| Shares Change (QoQ) | +39.36% |
| Owned by Insiders (%) | 0.57% |
| Owned by Institutions (%) | 52.52% |
| Float | 74.34M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 786.14 |
| Forward PS | n/a |
| PB Ratio | 1.37 |
| P/TBV Ratio | 1.58 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 354.59 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.75, with a Debt / Equity ratio of 0.01.
| Current Ratio | 8.75 |
| Quick Ratio | 8.61 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -339.98 |
Financial Efficiency
Return on equity (ROE) is -35.33% and return on invested capital (ROIC) is -23.44%.
| Return on Equity (ROE) | -35.33% |
| Return on Assets (ROA) | -20.27% |
| Return on Invested Capital (ROIC) | -23.44% |
| Return on Capital Employed (ROCE) | -31.64% |
| Weighted Average Cost of Capital (WACC) | 13.84% |
| Revenue Per Employee | $3,723 |
| Profits Per Employee | -$669,476 |
| Employee Count | 166 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -793,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +76.99% in the last 52 weeks. The beta is 1.76, so CATX's price volatility has been higher than the market average.
| Beta (5Y) | 1.76 |
| 52-Week Price Change | +76.99% |
| 50-Day Moving Average | 4.18 |
| 200-Day Moving Average | 3.63 |
| Relative Strength Index (RSI) | 57.04 |
| Average Volume (20 Days) | 1,358,379 |
Short Selling Information
The latest short interest is 13.00 million, so 11.40% of the outstanding shares have been sold short.
| Short Interest | 13.00M |
| Short Previous Month | 14.12M |
| Short % of Shares Out | 11.40% |
| Short % of Float | 17.48% |
| Short Ratio (days to cover) | 11.07 |
Income Statement
In the last 12 months, CATX had revenue of $618,000 and -$111.13 million in losses. Loss per share was -$1.36.
| Revenue | 618,000 |
| Gross Profit | -90.64M |
| Operating Income | -120.01M |
| Pretax Income | -112.44M |
| Net Income | -111.13M |
| EBITDA | -116.38M |
| EBIT | -120.01M |
| Loss Per Share | -$1.36 |
Full Income StatementBalance Sheet
The company has $270.93 million in cash and $4.23 million in debt, with a net cash position of $266.70 million or $2.34 per share.
| Cash & Cash Equivalents | 270.93M |
| Total Debt | 4.23M |
| Net Cash | 266.70M |
| Net Cash Per Share | $2.34 |
| Equity (Book Value) | 347.44M |
| Book Value Per Share | 3.05 |
| Working Capital | 243.87M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$92.37 million and capital expenditures -$14.95 million, giving a free cash flow of -$107.32 million.
| Operating Cash Flow | -92.37M |
| Capital Expenditures | -14.95M |
| Depreciation & Amortization | 3.64M |
| Net Borrowing | -54,000 |
| Free Cash Flow | -107.32M |
| FCF Per Share | -$0.94 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -19,419.58% |
| Pretax Margin | -18,194.17% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CATX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -16.38% |
| Shareholder Yield | -16.38% |
| Earnings Yield | -22.87% |
| FCF Yield | -22.09% |
Analyst Forecast
The average price target for CATX is $12.93, which is 209.33% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $12.93 |
| Price Target Difference | 209.33% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 15 |
| Revenue Growth Forecast (5Y) | 131.13% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 17, 2024. It was a reverse split with a ratio of 1:10.
| Last Split Date | Jun 17, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
CATX has an Altman Z-Score of 1.16 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.16 |
| Piotroski F-Score | 2 |
